Company intelligence / Profile preview
Regatta Therapeutics
Austin, Texas, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Regatta Therapeutics is a biotechnology company focused on the development of novel therapies for pulmonary arterial hypertension (PAH) and other rare cardiopulmonary diseases. The company's lead candidate, RGT-6115, is a soluble guanylate cyclase (sGC) stimulator designed to optimize therapeutic outcomes by improving hemodynamics with a favorable safety and tolerability profile. Founded by seasoned life science executives, the company sought to address significant unmet needs in the treatment of chronic cardiovascular conditions. In 2021, Regatta was acquired by United Therapeutics to complement its existing market-leading portfolio of pulmonary hypertension treatments.
- Therapeutic areas
- Cardiovascular
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on Regatta Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Regatta Therapeutics.